Boston Partners’s Imperva, Inc. IMPV Stock Holding History

Boston Partners’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-152,810	Closed	-$5.87M	–	809
2016 Q4	$5.87M	Buy	+152,810	New	+$6.21M	0.01%	476

Other funds holding IMPV

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Boston Partners's IMPV Position: Q1 2017 in Review

Boston Partners sold out of Imperva, Inc. (IMPV) in Q1 2017, closing a stake of 152,810 shares — an estimated $5.87M sold.

Boston Partners first reported a position in IMPV in Q4 2016 and held it in 1 quarter. The position peaked at $5.87M in Q4 2016. 182 funds tracked by Wall St. Rank hold IMPV as of Q1 2017.

Boston Partners reported no remaining Imperva, Inc. position as of Q1 2017 after selling out during the quarter.
Boston Partners sold 152,810 Imperva, Inc. shares in Q1 2017, an estimated $5.87M.
Boston Partners first reported a position in Imperva, Inc. in Q4 2016 and held it in 1 quarter.
Boston Partners's Imperva, Inc. position peaked at $5.87M in Q4 2016.
182 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2017.

Based on Boston Partners's 13F filing for Q1 2017, filed 3 May 2017.